Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · KRONOX LAB SCIENCES LTD · 22 September 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
KRONOX LAB SCIENCES LTD
NSE: KRONOX · BSE: 544187
NSE: KRONOX · BSE: 544187
Commodities › Chemicals › Chemicals & Petrochemicals › Specialty Chemicals
KRONOX LAB SCIENCES LTD
StateQ1 FY27 filed
Last close · 20 Sept 2026₹176.50
Market cap₹0.7k cr
TTM P/E · P/B · EV/EBITDA22.7 · 5.64 · 16.0
KRONOX LAB SCIENCES LTD is a Chemicals & Petrochemicals company listed on NSE. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY24–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 90 | 100 | 101 |
| EBITDA (ex other income) | 28 | 33 | 34 |
| margin % | 31.5 | 33.1 | 33.9 |
| Owners' profit | 21 | 25 | 28 |
| EPS, as reported (₹) | 5.81 | 6.91 | 7.51 |
| ROE % · ROCE % | 32.2 · 43.1 | 28.1 · 34.9 | 23.8 · 31.9 |
| Debt / equity (x) | 0.00 | 0.00 | 0.01 |
| Cash from operations | 17 | 32 | 24 |
| Capex | (12) | (3) | (3) |
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · KRONOX LAB SCIENCES LTD · 22 September 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 25 | 24 | 26 | 24 | 26 | 25 | 26 | 28 |
| Profit before tax | 9 | 9 | 8 | 8 | 9 | 9 | 11 | 10 |
| Net profit | 6 | 7 | 6 | 6 | 7 | 7 | 8 | 7 |
| EPS (₹) | 1.76 | 1.77 | 1.72 | 1.70 | 1.82 | 1.79 | 2.18 | 2.00 |
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| PIDILITE INDUSTRIES LTD | 1,60,507 | 60.6 | 14.53 | 42.5 | 22.4 | 28.0 | 14.9 | 28.6 |
| SRF LTD | 75,735 | 35.0 | 5.39 | 23.4 | 13.1 | 13.1 | 13.4 | 25.2 |
| GUJARAT FLUOROCHEM LTD | 50,160 | 81.9 | 6.34 | 39.7 | 7.3 | 8.7 | 13.5 | 27.7 |
| NAVIN FLUORINE INT. LTD | 43,479 | 55.0 | 10.94 | 39.2 | 16.7 | 16.4 | 23.0 | 37.5 |
| AETHER INDUSTRIES LIMITED | 21,738 | 92.2 | 8.85 | 59.0 | 8.9 | 11.4 | — | 33.8 |
| DEEPAK NITRITE LTD | 21,715 | 27.7 | 3.70 | 22.4 | 9.4 | 10.2 | 12.6 | 21.5 |
| AARTI INDUSTRIES LTD | 18,033 | 34.0 | 3.03 | 19.0 | 7.0 | 4.4 | 13.0 | 16.2 |
| ATUL LTD | 17,908 | 22.5 | 2.84 | 14.5 | 10.9 | 13.3 | 10.9 | 23.1 |
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 22.7 | 23.7 | 51 of 104 | 52% |
| P/B | 5.6 | 2.8 | 78 of 99 | 21% |
| ROCE | 31.8 | 10.3 | 6 of 108 | 95% |
| ROE | 23.8 | 8.1 | 6 of 101 | 95% |
| Debt / Equity | 0.0 | 0.2 | 24 of 101 | 77% |
| EBITDA margin | 36.3 | 15.5 | 5 of 99 | 96% |
| Revenue growth | 16.9 | 24.4 | 63 of 94 | 33% |
| Profit growth | 16.3 | 55.1 | 63 of 92 | 32% |
| Market cap | 655 | 707 | 56 of 108 | 49% |
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · KRONOX LAB SCIENCES LTD · 22 September 2026Page 3 of 3
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 17 Sept 2026 · 17th AGM results: all 4 resolutions passed; Rs 0.50 dividend declared | board shareholder meetings | low | — | — |
| 17 Sept 2026 · AGM results: all 4 resolutions passed, dividend of Rs 0.50 per share declared | compliance | minimal | — | — |
| 16 Sept 2026 · Kronox Lab Sciences 17th AGM: Final Dividend of Rs 0.50 Per Share Declared | board shareholder meetings | medium | — | — |
| 5 Sept 2026 · Kronox Lab Sciences: Indo Borax open offer DLOF filed at Rs 157.27 per share | strategic transactions | high | — | — |
| 4 Sept 2026 · Indo Borax files Draft Letter of Offer for open offer on Kronox Lab | strategic transactions | high | — | — |
| 30 Aug 2026 · Newspaper publication of 17th AGM notice for September 16, 2026 meeting | compliance | minimal | — | — |
| 28 Aug 2026 · Open Offer at Rs 157.27 per share by Indo Borax for 25.79% stake in Kronox | strategic transactions | high | — | — |
| 28 Aug 2026 · Open Offer by Indo Borax for Kronox Lab Sciences at Rs 157.27 per share | strategic transactions | high | — | — |
| 24 Aug 2026 · Record date fixed at Sept 9, 2026 for Rs 0.50 final dividend per share | corporate actions | high | — | — |
| 24 Aug 2026 · KRONOX Lab Sciences 17th AGM notice filed, dividend of Rs 0.50 per share | board shareholder meetings | low | — | — |
Source: exchange announcements; reaction = close-to-close from the filing's session.
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in